GT200200089A - Composicion farmaceutica liquida - Google Patents
Composicion farmaceutica liquidaInfo
- Publication number
- GT200200089A GT200200089A GT200200089A GT200200089A GT200200089A GT 200200089 A GT200200089 A GT 200200089A GT 200200089 A GT200200089 A GT 200200089A GT 200200089 A GT200200089 A GT 200200089A GT 200200089 A GT200200089 A GT 200200089A
- Authority
- GT
- Guatemala
- Prior art keywords
- pharmaceutical composition
- liquid pharmaceutical
- application
- composition
- hypoquinesia
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 239000007788 liquid Substances 0.000 title abstract 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 230000001663 anti-spastic effect Effects 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 210000001218 blood-brain barrier Anatomy 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 206010015037 epilepsy Diseases 0.000 abstract 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical class NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 abstract 1
- 231100000053 low toxicity Toxicity 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
LA PRESENTE INVENCION DESCRIBE UNA COMPOSICION FARMACEUTICA LIQUIDA DE UN ANALOGO DE GABA QUE TIENE UNA ACTIVIDAD ANTICONVULSIONANTE Y ANTIESPASTICA CON UNA BAJA TOXICIDAD AL CRUZAR LA BARRERA HEMATOENCEFALICA. EN LA SOLICITUD SE DESCRIBE COMPOSICION Y METODO PARA PREPARAR ESTA COMPOSICION FARMACEUTICA SIENDO UTIL EN PATOLOGIAS CEREBRALES TALES COMO EPILEPSIA, HIPOQUINESIA, TRAUMATISMOS CRANEALES Y ESTADOS DE ANSIEDAD, PANICO ENTRE OTROS, DESCRITOS EN LA SOLICITUD.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29383201P | 2001-05-25 | 2001-05-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GT200200089A true GT200200089A (es) | 2003-05-15 |
Family
ID=34699738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT200200089A GT200200089A (es) | 2001-05-25 | 2002-05-20 | Composicion farmaceutica liquida |
Country Status (5)
| Country | Link |
|---|---|
| EC (1) | ECSP034853A (es) |
| GT (1) | GT200200089A (es) |
| PY (1) | PY0211943A (es) |
| TN (1) | TNSN03125A1 (es) |
| UA (1) | UA75138C2 (es) |
-
2002
- 2002-04-29 UA UA20031110602A patent/UA75138C2/uk unknown
- 2002-05-20 GT GT200200089A patent/GT200200089A/es unknown
- 2002-05-22 PY PY200200211943A patent/PY0211943A/es unknown
-
2003
- 2003-07-08 TN TNPCT/IB2002/001500A patent/TNSN03125A1/fr unknown
- 2003-11-17 EC ECSP034853 patent/ECSP034853A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UA75138C2 (en) | 2006-03-15 |
| PY0211943A (es) | 2004-07-01 |
| TNSN03125A1 (fr) | 2005-12-23 |
| ECSP034853A (es) | 2003-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9712651A (pt) | cidos gama-aminobutìricos substituìdos com agentes farmacêuticos. | |
| Hilde et al. | Advice to stay active as a single treatment for low‐back pain and sciatica | |
| ATE515260T1 (de) | Stabile nanokapselsysteme für die verabreichung von wirkstoffen | |
| CR8858A (es) | Derivados de sulfamato y sulfamida para el tratamiento de epilepsia y trastornos relacionados | |
| CU23112A3 (es) | AMINOáCIDOS BICICLICOS COMO AGENTES FARMACéUTICOS | |
| ECSP077275A (es) | Novedosos derivados de heteroarilsulfamida benzofusionados utiles como agentes anticonvulsivos | |
| BR9813656A (pt) | Aminas como agentes farmacêuticos | |
| ES2176668T3 (es) | Aminoacidos ciclicos novedosos como agentes farmaceuticos. | |
| BRPI0407747A (pt) | agente terapêutico para lesão à medula espinhal compreendendo antagonista de interleucinas-6 | |
| CL2008000691A1 (es) | Compuestos derivados de dihidro y tetrahidro oxazolopirimidinonas sustituidas; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de la esquizofrenia, epilepsia, entre otras enfermedades. | |
| GT200400045A (es) | Sistema de liberacion controlada | |
| EP2409569A3 (en) | Method for administering GLP-1 molecules | |
| AR039269A1 (es) | Composiciones farmaceuticas topicas para el tratamiento de las dermatitis | |
| WO2007137164A3 (en) | Co-therapy for the treatment of epilepsy and related disorders | |
| WO2006055672A3 (en) | Methods and compositions for treating pain | |
| TW200740801A (en) | N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase | |
| UY30359A1 (es) | Coterapeutica para el tratamiento de epilepsia y trastornos relacionados i | |
| IL181445A0 (en) | Use of (halobenzyloxy)benzylamino-propanamides for the manufacture of medicaments active as sodium and/or calcium selective modulators | |
| BRPI0510931A (pt) | derivados de sulfamato e sulfamida para o tratamento de epilepsia e distúrbios relacionados | |
| PE20070680A1 (es) | Barra de cereal de grano entero baja en calorias | |
| EP2314571A3 (en) | Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents | |
| BRPI0415872A (pt) | ácidos nucleìcos ligando especificamente à grelina bioativa | |
| BRPI0408221A (pt) | dispositivos dispensadores | |
| BRPI0714008A2 (pt) | Sistema de embalagem para comportar e liberar seletivamente uma alíquota particulada. | |
| BRPI0507626A (pt) | compostos e composiçoes como moduladores de lxr |